Last update 31 Dec 2024
Acetaminophen/Hydrocodone/Promethazine
Last update 31 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms- |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), H1 receptor antagonists(Histamine H1 receptor antagonists), Opioid receptors agonists(Opioid receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC17H20N2S |
InChIKeyPWWVAXIEGOYWEE-UHFFFAOYSA-N |
CAS Registry60-87-7 |
View All Structures (3)
Related
2
Clinical Trials associated with Acetaminophen/Hydrocodone/PromethazineA Randomized, Double-Blind, Placebo- and Active-Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg (Hydrocodone 5 mg/Acetaminophen 325 mg/Promethazine 12.5 mg) as a Treatment for Moderate-to-Severe Acute Pain and the Prevention of Opioid-Induced Nausea and Vomiting (OINV) Following Orthopedic Surgery
A Double-Blind, Randomized, Placebo-Controlled, Multiple-dose Multi-Center Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain
100 Clinical Results associated with Acetaminophen/Hydrocodone/Promethazine
Login to view more data
100 Translational Medicine associated with Acetaminophen/Hydrocodone/Promethazine
Login to view more data
100 Patents (Medical) associated with Acetaminophen/Hydrocodone/Promethazine
Login to view more data
100 Deals associated with Acetaminophen/Hydrocodone/Promethazine
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Nausea | NDA/BLA | - | - | |
| Pain | NDA/BLA | - | - | |
| Acute Pain | Phase 3 | US | 02 Aug 2017 | |
| Drug-induced nausea and vomiting | Phase 3 | US | 02 Aug 2017 | |
| Vomiting | Phase 3 | US | 02 Aug 2017 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 3 | 349 | (Norco) | rjbxyjvoof(fxoidcvwgd) = nyxdfiuwpm kyluampgap (zwjxtiudbp, iamfprbnrr - dsnojkflzm) View more | - | 22 Mar 2023 | ||
Placebo (Placebo) | rjbxyjvoof(fxoidcvwgd) = gfqcjbktll kyluampgap (zwjxtiudbp, xdzqmuejhn - okmfjyxbjp) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free